Amgen Inc.
HIGH TITER RECOMBINANT AAV VECTOR PRODUCTION IN ADHERENT AND SUSPENSION CELLS

Last updated:

Abstract:

Disclosed are an in vitro method of producing a recombinant AAV virion in a mammalian host cell that comprises a functional adenoviral E1A gene (e.g., a HEK 293 cell) and rAAV virions made by the method.

Status:
Application
Type:

Utility

Filling date:

28 Jul 2021

Issue date:

25 Nov 2021